Why is Solara Active falling/rising?

As of 01-Aug, Solara Active Pharma Sciences Ltd is experiencing a decline in its stock price, currently at Rs 603.70, reflecting a decrease of Rs 35.0 or 5.48%. The stock has underperformed its sector by 2.32% today and has been on a downward trend for the last two days, with a total drop of 7.55% during this period. Although the stock opened with a gain of 4.42% and reached an intraday high of Rs 666.95, it also hit a low of Rs 600, indicating significant volatility with a wide trading range of Rs 66.95. Over the past week, the stock has seen a return of -13.10%, contrasting with the Sensex's minor decline of -1.06%. The company's recent performance shows a growth in net sales and positive results over the last four quarters, but it also faces challenges such as a weak long-term fundamental strength and a high debt to EBITDA ratio, which may contribute to investor concerns.
In the broader market context, the stock's short-term performance has significantly lagged behind the benchmark, with a 1-month return of -7.74% compared to the Sensex's -3.70%. The pharmaceuticals and drugs sector has also declined by 3.27%, adding to the negative sentiment surrounding Solara Active. Additionally, the increase in pledged promoter shares, now at 38.95%, raises concerns about the stock's stability in a falling market, potentially exerting further downward pressure on its price. Overall, while the company has shown some positive financial indicators, the combination of high volatility, declining investor participation, and broader sector weakness appears to be driving the stock's recent decline.